20 studies found for:    "cystinosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Cure Cystinosis International Registry
Conditions: Cystinosis;   Nephropathic Cystinosis;   Renal Fanconi Syndrome
Intervention:
2 Completed
Has Results
Cysteamine Eye Drops to Treat Corneal Crystals in Cystinosis
Condition: Cystinosis
Intervention: Drug: Cysteamine
3 Completed N Acetyl Cysteine for Cystinosis Patients
Conditions: Renal Disease;   Cystinosis
Intervention: Drug: N acetyl cysteine
4 Recruiting Use of Cysteamine in the Treatment of Cystinosis
Condition: Cystinosis
Intervention: Drug: Cysteamine
5 Completed Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
Condition: Cystinosis
Interventions: Drug: Cystagon® (Cysteamine Bitartrate);   Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
6 Completed Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of RP103 Compared to Cystagon® in Patients With Cystinosis
Condition: Cystinosis
Interventions: Drug: Cystagon® (Cysteamine Bitartrate) Capsules: 150 mg/50 mg;   Drug: RP103
7 Recruiting Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis
Conditions: Cystinosis;   Myopathy
Intervention: Drug: rh Growth Hormone
8 Completed New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis
Condition: Cystinosis
Intervention: Drug: Cysteamine
9 Recruiting A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications
Condition: Cystinosis
Intervention: Other: Cysteamine bitartrate
10 Completed The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study
Conditions: Pseudotumor Cerebri;   Cystinosis
Intervention:
11 Active, not recruiting Open-Label Safety & Superior Effectiveness Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Cystinosis
Condition: Cystinosis
Interventions: Drug: RP103 Q12H;   Drug: Cystagon Q6H
12 Recruiting Safety/Effectiveness Study of Cysteamine Delayed-release Capsules (RP103) in Cysteamine Treatment Naive Patients With Cystinosis
Condition: Cystinosis
Intervention: Drug: RP103 Q12H
13 Completed Kidney Transplantation in Patients With Cystinosis
Condition: Cystinosis
Intervention:
14 Completed Clinical and Biological Study of Sub-pigmentation During Infantile Cystinosis
Condition: Cystinosis
Intervention: Other: analysis of pigmentation
15 Completed Evaluation of Fanconi Syndrome and Cystinosis
Conditions: Cystinosis;   Fanconi Syndrome
Intervention:
16 Completed Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis
Condition: Cystinosis
Intervention:
17 Completed Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis
Condition: Cystinosis
Intervention: Drug: cysteamine hydrochloride
18 Active, not recruiting Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103)
Condition: Cystinosis
Intervention: Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
19 Completed
Has Results
Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™
Conditions: Cystinosis;   Nephropathic Cystinosis
Intervention: Drug: Cysteamine bitartrate
20 Completed Salivary Proteins in Disease and Health
Conditions: Diabetes Mellitus;   Sarcoidosis;   Dental Caries;   Sjorgren's Syndrome;   Cystinosis;   Head and Neck Neoplasms
Intervention:

Indicates status has not been verified in more than two years